Amneal Pharmaceuticals

AMRX

NASDAQHealth Care

Income Statement

Total Revenue$2.79B

Gross Profit$1.02B

Operating Income$249.33M

EBITDA$396.76M

EBIT$160.57M

Pre-tax Income$139.21M

Net Income$-116.89M

Cash Equivalent$74.5M

Total Debt$2.68B

Book Value$-81.05M

Book Value Per Share-0.26

Return on Equity (ROE)-424.61%

Return on Assets (ROA)-3.34%

Return on Invested Capital (ROI)-3.09%

Net Profit Margin-4.18%

Current Ratio1.41

Quick Ratio0.82

Long-Term Debt / Equity122.72